【レポートの概要（一部）】
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Parent market
• Market characteristics
• Value Chain Analysis
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2019
• Market Outlook
• Market size and forecast 2019-2024
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY TYPE
• Market segmentation by type
• Comparison by type
• Multivalent conjugate vaccine – Market size and forecast 2019-2024
• Monovalent conjugate vaccine – Market size and forecast 2019-2024
• Market opportunity by type
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2019-2024
• Europe – Market size and forecast 2019-2024
• Asia – Market size and forecast 2019-2024
• ROW – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Increasing research activities for novel conjugate vaccine development
• Emergence of strategies to improve conjugate vaccine manufacturing
• Increasing efforts for stockpiling of conjugate vaccines
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Aurobindo Pharma Ltd.
• GlaxoSmithKline Plc
• Integrated Biotherapeutics Inc.
• Merck & Co. Inc.
• Mitsubishi Tanabe Pharma Corp.
• Pfenex Inc.
• Pfizer Inc.
• Sanofi
• Serum Institute of India Pvt. Ltd.
• Sun Pharmaceutical Industries Ltd.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors: Key offerings
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Type – Market share 2019-2024 (%)
Exhibit 19: Comparison by type
Exhibit 20: Multivalent conjugate vaccine – Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Multivalent conjugate vaccine – Year-over-year growth 2020-2024 (%)
Exhibit 22: Monovalent conjugate vaccine – Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Monovalent conjugate vaccine – Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by type
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America – Year-over-year growth 2020-2024 (%)
Exhibit 30: Top 3 countries in North America
Exhibit 31: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 32: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 33: Top 3 countries in Europe
Exhibit 34: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 35: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 36: Top 3 countries in Asia
Exhibit 37: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 38: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 39: Top 3 countries in ROW
Exhibit 40: Key leading countries
Exhibit 41: Market opportunity
Exhibit 42: Impact of drivers and challenges
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: Aurobindo Pharma Ltd. – Vendor overview
Exhibit 49: Aurobindo Pharma Ltd. – Business segments
Exhibit 50: Aurobindo Pharma Ltd. – Organizational developments
Exhibit 51: Aurobindo Pharma Ltd. – Geographic focus
Exhibit 52: Aurobindo Pharma Ltd. – Key offerings
Exhibit 53: Aurobindo Pharma Ltd. – Key customers
Exhibit 54: GlaxoSmithKline Plc – Vendor overview
Exhibit 55: GlaxoSmithKline Plc – Business segments
Exhibit 56: GlaxoSmithKline Plc – Organizational developments
Exhibit 57: GlaxoSmithKline Plc – Geographic focus
Exhibit 58: GlaxoSmithKline Plc – Segment focus
Exhibit 59: GlaxoSmithKline Plc – Key offerings
Exhibit 60: GlaxoSmithKline Plc – Key customers
Exhibit 61: Integrated Biotherapeutics Inc. – Vendor overview
Exhibit 62: Integrated Biotherapeutics Inc. – Business segments
Exhibit 63: Integrated Biotherapeutics Inc. – Key offerings
Exhibit 64: Integrated Biotherapeutics Inc. – Key customers
Exhibit 65: Merck & Co. Inc. – Vendor overview
Exhibit 66: Merck & Co. Inc. – Business segments
Exhibit 67: Merck & Co. Inc. – Organizational developments
Exhibit 68: Merck & Co. Inc. – Geographic focus
Exhibit 69: Merck & Co. Inc. – Segment focus
Exhibit 70: Merck & Co. Inc. – Key offerings
Exhibit 71: Merck & Co. Inc. – Key customers
Exhibit 72: Mitsubishi Tanabe Pharma Corp. – Vendor overview
Exhibit 73: Mitsubishi Tanabe Pharma Corp. – Business segments
Exhibit 74: Mitsubishi Tanabe Pharma Corp. – Organizational developments
Exhibit 75: Mitsubishi Tanabe Pharma Corp. – Geographic focus
Exhibit 76: Mitsubishi Tanabe Pharma Corp. – Key offerings
Exhibit 77: Mitsubishi Tanabe Pharma Corp. – Key customers
Exhibit 78: Pfenex Inc. – Vendor overview
Exhibit 79: Pfenex Inc. – Business segments
Exhibit 80: Pfenex Inc. – Organizational developments
Exhibit 81: Pfenex Inc. – Key offerings
Exhibit 82: Pfenex Inc. – Key customers
Exhibit 83: Pfizer Inc. – Vendor overview
Exhibit 84: Pfizer Inc. – Business segments
Exhibit 85: Pfizer Inc. – Organizational developments
Exhibit 86: Pfizer Inc. – Geographic focus
Exhibit 87: Pfizer Inc. – Segment focus
Exhibit 88: Pfizer Inc. – Key offerings
Exhibit 89: Pfizer Inc. – Key customers
Exhibit 90: Sanofi – Vendor overview
Exhibit 91: Sanofi – Business segments
Exhibit 92: Sanofi – Organizational developments
Exhibit 93: Sanofi – Geographic focus
Exhibit 94: Sanofi – Segment focus
Exhibit 95: Sanofi – Key offerings
Exhibit 96: Sanofi – Key customers
Exhibit 97: Serum Institute of India Pvt. Ltd. – Vendor overview
Exhibit 98: Serum Institute of India Pvt. Ltd. – Product segments
Exhibit 99: Serum Institute of India Pvt. Ltd. – Organizational developments
Exhibit 100: Serum Institute of India Pvt. Ltd. – Key offerings
Exhibit 101: Serum Institute of India Pvt. Ltd. – Key customers
Exhibit 102: Sun Pharmaceutical Industries Ltd. – Vendor overview
Exhibit 103: Sun Pharmaceutical Industries Ltd. – Business segments
Exhibit 104: Sun Pharmaceutical Industries Ltd. – Organizational developments
Exhibit 105: Sun Pharmaceutical Industries Ltd. – Geographic focus
Exhibit 106: Sun Pharmaceutical Industries Ltd. – Key offerings
Exhibit 107: Sun Pharmaceutical Industries Ltd. – Key customers
Exhibit 108: Validation techniques employed for market sizing
Exhibit 109: Definition of market positioning of vendors
【レポート販売概要】
■ タイトル：コンジュゲートワクチンの世界市場：種類別、地域別■ 英文：Conjugate Vaccines Market by Type and Geography - Forecast and Analysis 2020-2024
■ 発行日：2019年12月10日
■ 調査会社：Technavio
■ 商品コード：IRTNTR40714
■ 調査対象地域：グローバル
- 潰瘍性大腸炎治療薬の世界市場2016-2020About Ulcerative Colitis Ulcerative colitis is a type of inflammatory bowel disease (IBD) that affects the colon and rectum. Inflammation and ulcers are formed in the innermost lining of the colon and rectum, resulting in the production of pus and mucous. Based on the extent of inflammation and the location, ulcerative colitis can be of different types: ulcerative proctitis, proctosigmoiditis, lef …
- 世界の小型自動車用電線（ワイヤー）市場【2015年1月更新版】This latest just-auto report edition offers a global review of the OE electric and electronic distribution systems sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE electric and electronic distribution systems market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Pr …
- 抗真菌薬の世界市場分析：医薬品別（アゾール、エキノカンジン、ポリエン、アリルアミン）、症状別（皮膚真菌症、アスペルギルス症、カンジダ症）、セグメント予測 2014-2025The global antifungal drugs market was valued at USD 10.7 billion in 2015 and is expected to reach a value of USD 12.6 billion by 2025. The increasing incidence of fungal infections worldwide is the key contributing factor for the growth of the antifungal drugs market in the coming years. Rising adoption of immunosuppressive andantineoplastic agents, prosthetic devices and grafts, and broad-spectr …
- サムスン電子のIoT戦略、開発動向The world is moving beyond standalone devices into a new era in which everything is connected. The Internet of Things (IoT) refers to uniquely identifiable objects (things) and their virtual representations in an Internet-like structure. Stated differently, the concept involves the notion that there are many things (assets, objects, etc.) in the world that may be addressed/labeled/cataloged for va …
- 4G機器の世界市場：コンポーネント別、技術別Wireless mobile communications are generally defined by generation designations. 4G is a fourth-generation of mobile network technology that enables faster internet than earlier generations such as 2G and 3G networks. The 4G equipment are categorized into Long-term Equipment (LTE) and Wi-max equipment. These equipment enable to increase network capacity and faster data transmission rates in areas …
- 世界のパワートランジスタ（Power Transistor）市場動向（2012-2016）TechNavio's analysts forecast the Global Power Transistor market to grow at a CAGR of 7.32 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for power efficient electronic products. The Global Power Transistor market has also been witnessing the convergence of different technologies on a single platform. However, slowdown in the g …
- 沈降シリカの世界市場分析：用途別（ゴム、農薬、オーラルケア、食品産業）、セグメント予測Precipitated silica market is expected to reach USD 3.69billion by 2022, according to a new report by Grand View Research, Inc. The market is expected to witness substantial growth on account of its extensive use in rubber, toothpaste, and food industry. Growing demand for rubber grade products is expected to propel precipitated silica demand. Rubber has extensive usage in the automotive, construc …
- フレキシブルAC伝送システム（FACTS）の世界市場予測（～2024年）FACTS market to grow at CAGR of 6.0% from 2019 to 2024 The global flexible AC transmission systems (FACTS) market size is projected to reach USD 1.7 billion by 2024 from USD 1.2 billion in 2019, at a CAGR of 6.0%. Major drivers for the market’s growth are increasing benefits offered by FACTS, growth in transmission line, rising focus on energy generation using renewable sources, and surging demand …
- 細胞及び組織分析製品の世界市場：細胞・組織キャラクタリゼーション、生体試料作製、細胞・組織分離About Cell and Tissue Analysis Products Cell and tissue analysis refers to the study of cells or tissues to identify and analyze the structure and function of cells and tissues. Various biospecimen preparation, cell and tissue separation, and cell and tissue characterization products are used to isolate and assess cells and tissue. The predominant technologies used in cell and tissue analysis are …
- 医療用温度管理装置の世界市場：表面用装置、血管用装置、患者加温装置、患者クーリング装置The global market is expected to grow at a CAGR of 2.3% to reach USD 2,576.8 Million by 2020. Number of factors such as the worldwide development of technologically advanced temperature management systems, increase in aging population (which in turn is increasing the demand for age-related surgeries), and growing prevalence of cancer and cardiovascular diseases is propelling the growth of the glob …
- Drax Group plc：発電所及びSWOT分析2013Drax Group plc - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summarized and deta …
- Vanguard Natural Resources, LLC：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Vanguard Natural Resources, LLC Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Vanguard Natural Resources, LLC Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is …
- 電子ビーム・ウェハ検査装置の世界市場2015-2019Electron beam or e-beam wafer inspection system is a semiconductor fab equipment, which is used during the semiconductor wafer manufacturing process, to find a defect in the wafers before packaging it. As the use of semiconductor wafer is predominant over a wide range of industries like consumer electronics, automotive, and industrial segment, the e-beam wafer inspection system is certain to grow. …
- 世界のエピクロルヒドリン市場The increasing demand of Epichlorohydrin in China and growth in the end-user segments such as paint and electronic industry are key factors to drive the global ECH market. Epoxy resin is the main application which consumes a large part of Epichlorohydrin. Properties of epoxy resin make it suitable for wide variety of applications such as paints, electrical & electronics, construction, wind turbine …
- 世界のスマートフォン市場動向（2014-2018）TechNavio’s analysts forecast the Global Smartphones market will grow at a CAGR of 15.3 percent over the period 2013-2018. One of the key factors contributing to this market growth is the declining ASP of smartphones. The Global Smartphones market has also been witnessing increasing demand for large-screen smartphones. However, the high production cost could pose a challenge to the growth of this …
